Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intraoperative Dexamethasone on Post-op Dry Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* undergoing bilateral cataract surgery~Exclusion Criteria:~* central corneal staining with fluorescein and/or a tear film osmolarity of greater than 340 in either eye

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Intracameral dexamethasone 9% + postoperative topical prednisolone acetate (Type: EXPERIMENTAL): dexamethasone intraocular suspension, 9% injected intracamerally at the time of cataract surgery + topical ophthalmic prednisolone acetate for 3 weeks post-operatively
- postoperative topical prednisolone acetate (Type: ACTIVE_COMPARATOR): topical ophthalmic prednisolone acetate for 3 weeks post-operatively

Based on this trial design, predict the completion outcome and termination type (if applicable).